JY
AEMD icon

Jeff Yass’s Aethlon Medical AEMD Stock Holding History

Jeff Yass’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-92
Closed -$18.3K – 11865
2024
Q2 		$18.3K Buy
+92
New +$36.2K ﹤0.01% 11684
2023
Q3 		– Sell
-3
Closed -$4.65K – 11927
2023
Q2 		$4.65K Buy
+3
New +$4.39K ﹤0.01% 11833
2023
Q1 		– Sell
-12
Closed -$13.3K – 12466
2022
Q4 		$13.3K Buy
+12
New +$21.9K ﹤0.01% 11878
2022
Q2 		– Sell
-3
Closed -$17K – 12783
2022
Q1 		$17K Sell
3
-5
-63% -$29.8K ﹤0.01% 12660
2021
Q4 		$61K Buy
+8
New +$91.1K ﹤0.01% 12443
2020
Q2 		– Sell
-3
Closed -$15K – 10039
2020
Q1 		$15K Buy
+3
New +$25.4K ﹤0.01% 9986
2019
Q3 		– Hold
0
– -$9K – 10088
2019
Q2 		– Hold
0
– – – 10083
2018
Q3 		– Sell
-1
Closed -$66K – 9110
2018
Q2 		$66K Buy
+1
New +$78.4K ﹤0.01% 9194

Other funds holding AEMD

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jeff Yass's AEMD Position: Q3 2024 in Review

Jeff Yass sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 92 shares — an estimated $18.3K sold.

Jeff Yass first reported a position in AEMD in Q2 2018 and held it in 7 quarters. The position peaked at $66K in Q2 2018. 12 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

  • Jeff Yass reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 92 Aethlon Medical shares in Q3 2024, an estimated $18.3K.
  • Jeff Yass first reported a position in Aethlon Medical in Q2 2018 and held it in 7 quarters.
  • Jeff Yass's Aethlon Medical position peaked at $66K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.